aml diagnosis
Item
patients must have aml based on french-american-british (fab) criteria.
boolean
C0023467 (UMLS CUI [1])
enzyme parameters
Item
patients must have a total bilirubin of < 2.0 mg/dl, sgot < 90 iu/ml, alkaline phosphatase < 250 u/ml and a serum creatinine < 2.0 mg/dl.
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
age
Item
age 18 years or greater.
boolean
C0001779 (UMLS CUI [1])
hematologic malignancy
Item
history of an antecedent hematologic malignancy such as myelodysplastic syndromes (mds).
boolean
C0376545 (UMLS CUI [1])
infection
Item
uncontrolled infection
boolean
C0517627 (UMLS CUI [1])
concomitant malignancy
Item
history of a previous or concomitant malignancy other than non-melanoma skin cancer.
boolean
C2735088 (UMLS CUI [1])
C0009488 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
cns leukemia
Item
evidence of central nervous system (cns) leukemia.
boolean
C1332884 (UMLS CUI [1])
corticosteroid use
Item
current use of corticosteroids.
boolean
C0001617 (UMLS CUI [1])
prior aml treatment
Item
prior treatment for aml, other than hydroxyurea.
boolean
C0087111 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])